Related Experiment Videos
Human breast cancer cells contain an error-prone DNA replication apparatus
J W Sekowski1, L H Malkas, L Schnaper
1Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore 21201, USA.
Cancer Research
|August 12, 1998
Summary
The DNA synthesome (a protein complex) from cancer cells is mutagenic, unlike that from normal cells. This difference in DNA replication fidelity contributes to genetic mutations observed in cancer.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Mechanisms of genetic errors and genomic instability in cancer remain unclear.
- Human cells possess a DNA synthesome, a protein complex essential for DNA replication.
- Previous studies have characterized the DNA synthesome's role in DNA replication.
Purpose of the Study:
- To investigate the role of the DNA synthesome in cancer cell genetic instability.
- To compare the DNA replication fidelity of the DNA synthesome from malignant and nonmalignant breast cells.
Main Methods:
- Isolated DNA synthesomes from malignant and nonmalignant human breast cells.
- Performed DNA replication fidelity analyses on isolated DNA synthesomes.
- Quantified mutations including insertions, deletions, and mismatches.
Main Results:
- The DNA synthesome derived from malignant breast cells exhibited mutagenic properties.
- Replication fidelity decreased in tumor cells, but not due to increased proliferation or synthetic activity.
- The ratios of specific mutation types (insertions, deletions, mismatches) were similar between malignant and nonmalignant cell synthesomes, despite higher overall mutation rates in cancer cells.
Conclusions:
- The study identifies a cancer-specific mechanism contributing to increased genetic mutations.
- The malignant cell DNA synthesome's mutagenicity is a novel finding in cancer research.
- This research provides a unique molecular explanation for increased genetic errors in cancer cells.